Download the new health and life sciences report now for insights on the future of HLS, compliant commerce, and why embracing digital patient engagement solutions is the key to driving loyalty, brand valuation, and revenue through COVID-19 and beyond
We continue to grapple with a global pandemic and its effect on the economy, alongside political unrest in multiple countries and governmental decisions that will have monumental implications for countries across the globe.
At the beginning of 2020, Sundar Pichai, CEO of US tech giant Alphabet, made a plea for a regulatory framework for AI.
Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced a proprietary technology that can form biological nanoparticles as small as 50 nm and announced a new near-term business target for 2021 to deliver its first biologics Proof of Concept project for this new technology with a pharmaceutical or biotech partner.
The Medicines Manufacturing Innovation Centre: A unique, state-of-the-art facility offering transformative solutions in small molecule and fine chemical manufacturing.
A #PharmaIntegrates highlight was hearing from @TakedaPharma's Andy Plump as he spoke about international collaborative initiatives for COVID-19 R&D, the status of progress on vaccines & therapeutic agents and data sharing. Watch back here: https://www.lifescienceintegrates.com/pharma-integrates-2020-track-1-recorded-sessions/
#Medtech companies are operating in a relatively new ecosystem that does not yet provide clear paths to monetisation. For digital solutions to become a viable revenue stream, leaders must rethink their traditional business models. Read the full whitepaper: https://www.huronconsultinggroup.com/insights/capturing-value-digital-innovation-medtech
